Tectonic Therapeutic (TECX) Interest Expenses (2017 - 2026)
Tectonic Therapeutic (TECX) reported Interest Expenses of $8000.0 for Q1 2026, down 60.0% year-over-year from $20000.0 in Q1 2025, and down 33.33% quarter-over-quarter from $12000.0 in Q4 2025.
Tectonic Therapeutic (TECX) Interest Expenses (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Interest Expenses data on file, last reported at $8000.0 in Q1 2026.
- Interest Expenses for Q1 2026 came in at $8000.0, down 60.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $51000.0 (down 46.32% YoY), and the FY2025 annual result was $63000.0, down 41.12% from the prior year.
- Interest Expenses fell to $8000.0 in Q1 2026 per TECX's latest filing, from $12000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $45000.0 in Q1 2022 and troughed at $8000.0 in Q1 2026.
- A 5-year average of $25538.5 and a median of $25000.0 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2026: Interest Expenses surged 80.0% in 2022, then plunged 60.0% in 2026.
- A 5-year view of Interest Expenses shows it stood at $45000.0 in 2022, then decreased by 24.44% to $34000.0 in 2023, then slumped by 35.29% to $22000.0 in 2024, then plunged by 45.45% to $12000.0 in 2025, then tumbled by 33.33% to $8000.0 in 2026.
- Business Quant data shows TECX's Interest Expenses at $8000.0 in Q1 2026, $12000.0 in Q4 2025, and $14000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -5.58 Mn |
| 10 | Tectonic Therapeutic | 528.16 Mn | 291.27 Mn | - | 8,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |